Syros Pharmaceuticals Inc.

(NASDAQ:SYRS) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology and other related markets that address gene control and cancer. The Company operates only in the United States.

Contact Information

Website: www.syros.com
Email: hannahd@sternir.com
Main Phone: +1 617 744-1340
Address: 35 CambridgePark Drive
Address 2: 4th Floor
State: MA
City / Town: Cambridge
Country: US
Postal Code: 02140

Issuer Information

Exchange: NGS
CEO: Nancy A. Simonian
Employees: 103
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A